Last reviewed · How we verify
NCT05130476
Near-infrared Imaging Techniques for Identifying and Preserving Viable Parathyroid Glands During Thyroidectomy
NA trial testing Near-infrared-induced autofluorescence and indocyanine green near-infrared angiography in Hypoparathyroidism Postprocedural in 155 participants. Completed in 20 November 2024.
13 October 2023
Quick facts
| Lead sponsor | Odense University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 155 |
| Start date | 1 October 2021 |
| Primary completion | 13 October 2023 |
| Estimated completion | 20 November 2024 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Near-infrared-induced autofluorescence and indocyanine green near-infrared angiography
Conditions studied
- Hypoparathyroidism Postprocedural — all drugs for Hypoparathyroidism Postprocedural →
Sponsor
Odense University Hospital
Who can join
18 and older, any sex, with Hypoparathyroidism Postprocedural. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The parathyroid glands and their blood vessels are notoriously difficult to visualize and may therefore be unintentionally and irrevocably damaged during thyroid surgery. This project investigates new surgeon-performed imaging techniques that visualize the parathyroid glands and their vessels in real-time during thyroid surgery. The purpose is to examine, in a matched cohort study, whether the implementation of near-infrared-induced autofluorescence for identification of the parathyroid glands, combined with indocyanine green near-infrared angiography of the parathyroid feeding vessels, can reduce the incidence of postoperative hypocalcaemia in patients undergoing total and completion thyroidectomy at Odense University Hospital.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05130476
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypoparathyroidism Postprocedural
Currently open trials in the same condition.
- NCT06961071 — Parathyroid Allotransplant for Treatment of Hypoparathyroidism · Phase 1, PHASE2 · recruiting
- NCT05117853 — Autofluorescence and Indocyanine Green to Avoid Hypocalcemia After Thyroidectomy · Phase 3 · recruiting
- NCT03249012 — Quality of Life Related to Different Treatment Protocols for Post-thyroidectomy Hypoparathyroidism · NA · recruiting
Other Odense University Hospital trials
Trials by the same sponsor.
- NCT07163091 — Bracing After Ankle Fracture · NA · not yet recruiting
- NCT07521696 — Physical Recovery During Bracing After Ankle Fracture (Re-BAF) · NA · not yet recruiting
- NCT07466212 — QoLIDia: Quality of Life in Cancer Patients With Diabetes During Immunotherapy · not yet recruiting
- NCT07191379 — Self-administered Subcutaneous Daratumumab in Patients With Multiple Myeloma · Phase 4 · not yet recruiting
- NCT07170085 — Positioning of Children With Acute Respiratory Insufficiency · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05130476 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Odense University Hospital
- Last refreshed: 16 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05130476.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing